|
LOC400927 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.100200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.886360E-01 |
| Normal-vs-Stage2 |
5.514400E-01 |
| Normal-vs-Stage3 |
6.098200E-02 |
| Normal-vs-Stage4 |
3.336500E-02 |
| Stage1-vs-Stage2 |
5.918400E-01 |
| Stage1-vs-Stage3 |
3.011000E-01 |
| Stage1-vs-Stage4 |
2.137800E-01 |
| Stage2-vs-Stage3 |
3.093000E-01 |
| Stage2-vs-Stage4 |
1.661000E-01 |
| Stage3-vs-Stage4 |
4.985200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.167000E-01 |
| Normal-vs-AfricanAmerican |
2.535400E-01 |
| Normal-vs-Asian |
4.563400E-03 |
| Caucasian-vs-AfricanAmerican |
4.675200E-01 |
| Caucasian-vs-Asian |
5.302300E-03 |
| AfricanAmerican-vs-Asian |
1.347410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.587800E-01 |
| Normal-vs-Female |
5.218600E-01 |
| Male-vs-Female |
4.564200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.041610E-01 |
| Normal-vs-Extreme_Weight |
3.263400E-01 |
| Normal-vs-Obese |
2.970800E-01 |
| Normal-vs-Extreme_Obese |
9.537200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.922600E-01 |
| Normal_Weight-vs-Obese |
2.950200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.547960E-01 |
| Extreme_Weight-vs-Obese |
9.741600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.723400E-01 |
| Obese-vs-Extreme_Obese |
4.891400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.180000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.745800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.095200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.683600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.911800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.804800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.473800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.337600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.751700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.299420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.200600E-01 |
| Normal-VS-Type2 PRCC |
1.298250E-02 |
| Normal-VS-KIRP CIMP |
1.703370E-03 |
| Normal-VS-Unclassified PRCC |
6.987000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.66079999974755E-07 |
| Type1 PRCC-VS-KIRP CIMP |
3.52420000004905E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
9.070800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.011160E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.662900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.960640E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.105800E-02 |
| Normal-vs-N1 |
1.811640E-01 |
| Normal-vs-N2 |
3.219200E-01 |
| N0-vs-N1 |
4.707800E-01 |
| N0-vs-N2 |
6.028400E-01 |
| N1-vs-N2 |
4.803400E-01 |
|
|
